Guaiazulene is the deep-blue azulene derivative associated with blue chamomile-like materials and blue cypress-type oils. In the AromaForge archive it is especially relevant because blue cypress records note that guaiazulene forms during distillation and helps explain the oil's blue color. Public literature supports identity, regulatory use as an externally applied cosmetic color additive in the United States, and a mixed preclinical bioactivity record, but safety interpretation should stay nuanced because some studies also report photomutagenicity or photo-DNA-damage concerns under irradiation conditions.
Chemical identity and composition
PubChem identifies guaiazulene as C15H18, and the current U.S. color-additive regulation describes it principally as 1,4-dimethyl-7-isopropyl-azulene. In the local archive, blue cypress lists guaiazulene at 0.43% and explicitly notes that it forms during distillation, which is why the oil develops its characteristic blue tone.
Aroma and practical use
- Use the recorded soft, woody, balsamic, slightly spicy descriptors to explore a blend's scent character; perceived strength also depends on the other ingredients.
- Read the route, preparation and experimental context before using a study finding to choose an oil.
Reported benefits and effects
Findings retain their study context. An animal or laboratory result describes that experiment.
A 2020 PBMC study found that 2-5 microM guaiazulene exposed to red laser light generated more singlet oxygen and reduced RANTES and PGE2 levels in TNF-alpha-inflamed peripheral blood mononuclear cells without affecting viability.
This supports a controlled photodynamic anti-inflammatory interpretation, not a standalone topical efficacy claim.
This experimental finding does not establish benefit, dose or safety in people using this blend.
A 2003 mutagenesis paper reported that guaiazulene and azulene were photomutagenic in Salmonella TA102 when tested with concomitant UVA and or visible-light irradiation.
This is a key cautionary finding because it complicates simple 'skin-soothing' narratives around guaiazulene.
This experimental finding does not establish benefit, dose or safety in people using this blend.
A later comprehensive photogenotoxicity assessment reported that neither azulene nor guaiazulene showed photomutagenic or photogenotoxic activity in the tested battery, illustrating that the photosafety literature is not fully one-directional.
The accessible guaiazulene photosafety record is therefore mixed rather than settled.
This experimental finding does not establish benefit, dose or safety in people using this blend.
A 2012 neonatal dermatitis paper evaluated a guaiazulene-containing pomade for recalcitrant diaper dermatitis in NICU patients, indicating that guaiazulene has reached human-use dermatology contexts, although this remains product-level rather than isolated-constituent proof.
This source supports real-world formulation relevance but should not be overread as isolated guaiazulene efficacy evidence.
Apply this finding only to the studied preparation, participants, route and outcome. It does not establish the same result for a custom oil blend.
Use concerns and concentration limits
Sensitization concernNot flagged
Not flagged in the current model. This is not proof of absence or unrestricted safety.
Phototoxicity concernNot flagged
Not flagged in the current model. This is not proof of absence or unrestricted safety.
Oxidation concernNot flagged
Not flagged in the current model. This is not proof of absence or unrestricted safety.
Penetration enhancementNot flagged
Not flagged in the current model. This is not proof of absence or unrestricted safety.
No numeric constituent-specific use limit is available here. Missing is not an unrestricted-use clearance.
Current U.S. regulation states that guaiazulene may be safely used in externally applied cosmetics in amounts consistent with good manufacturing practice.
The source assessment applies to its specified exposure and preparation; this entry is not an unrestricted-use clearance.
No direct public citation is attached to this entry.
The photosafety literature is mixed: some studies report photomutagenicity or photo-induced DNA-damage concerns under irradiation conditions, while later testing found no photomutagenic or photogenotoxic activity in its battery.
This reference does not establish a therapeutic result or a safe use level for a custom oil blend.
No direct public citation is attached to this entry.
A 1984 case report indexed in PubMed describes allergic contact cheilitis to guaiazulene, so individual topical intolerance remains possible even though the ingredient is used cosmetically.
This reference does not establish a therapeutic result or a safe use level for a custom oil blend.
No direct public citation is attached to this entry.
Constituents it may interact with
No constituent-pair interaction is recorded for this identity. The report does not assume either amplification or incompatibility.
How the effects were investigated
photodynamic_singlet_oxygen_generation
A 2020 PBMC study reported that red-laser activation of guaiazulene generated singlet oxygen and reduced inflammatory markers without reducing cell viability under those experimental conditions.
This experimental finding does not establish benefit, dose or safety in people using this blend.
photoactivated_reactive_oxygen_and_dna_damage_risk
Photogenotoxicity papers indicate that light-activated guaiazulene can generate reactive species associated with bacterial photomutagenicity and DNA-damage signals in some test systems.
This experimental finding does not establish benefit, dose or safety in people using this blend.
What this report cannot establish
- A reported constituent percentage does not establish an effective human therapeutic dose or the amount absorbed into the body.
- The presence of a constituent does not guarantee a clinical benefit, rash treatment or sleep improvement from a custom blend.
- An unflagged concern or missing use limit does not establish safety for ingestion, inhalation, skin exposure or a particular person.
- A candidate constituent interaction does not establish that two oils amplify one another at the selected proportions.
- Constituent descriptors alone do not establish a precise top, heart or base lifetime in a finished blend.
Known data gaps (5)
- Most guaiazulene bioactivity literature is preclinical, formulation-level, or review-based rather than isolated human clinical evidence.
- The accessible photosafety literature is mixed and would benefit from a deeper full-text regulatory review before making strong safety claims.
- Mechanistic claims outside photoactivation-related work remain early and should be treated cautiously.
- No constituent-specific numeric dermal reference is available here.
- Some findings do not record an explicit exposure route; consult the linked study before applying them to a use.